Format

Send to

Choose Destination
See comment in PubMed Commons below
Bull Acad Natl Med. 2009 Dec;193(9):1969-78; discussion 1978-9.

[Epithelial-mesenchymal transitions in cancer onset and progression].

[Article in French]

Author information

1
Institute of Molecular Cell Biology, Experimental Therapeutic Center, 61 Biopolis Drive and Cancer Science Institute, 28 Medical Drive 117456, National University of Singapore, Republic of Singapore. jpthiery@imcb.a-star.edu.sg

Abstract

Epithelial-mesenchymal transition (EMT) is a major process controlling multiple developmental events. The mesenchyme appeared as a transient state in diploblasts more than 800 million years ago. EMT has been conserved through evolution to control morphogenetic events, such as the formation of the three primary germ layers during gastrulation. Interestingly, related signal transduction pathways are remarkably conserved in many species. In the animal kingdom, EMT controls the intercellular adhesion machinery and its associated cytoskeleton. EMT pathways are also intimately involved in determination and differentiation programs, and are reactivated in adult tissues following injury or exposure to toxic agents. EMT is likely to play a role in early steps of carcinoma invasion, enabling blood or lymph vessel intravasation. Mesenchymal-like carcinoma cells undergo a mesenchymal to epithelial transition at distant sites from the primary tumor, and eventually form macrometastases. The mesenchymal-like state of cancer cells confers stemness, protection from cell death, immune escape and, most importantly, resistance to conventional and targeted therapies. Current strategies based on the EMT concept are aimed at designing new therapeutic approaches that interfere with the plasticity of carcinoma cells.

PMID:
20666011
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center